Corrections Belong in the Record

Send a source-based correction

The editorial desk welcomes corrections to citations, study descriptions, approval language, and compounding context. The most useful message identifies the page, quotes the sentence at issue, and supplies a primary or authoritative source supporting the proposed change. Please distinguish a newly published finding from a regulatory update; both matter, but answer different questions.

Editorial mailbox: editors@fdapeptides.com

Messages are reviewed for accuracy and relevance. Publication is not guaranteed, and the desk does not accept paid placement, product samples, affiliate arrangements, or claims that cannot be checked against a stable source. A promotional assertion does not become evidence because it arrives with confident typography.

What this desk cannot answer

FDA Peptides Brief does not provide individual medical guidance, interpret symptoms, recommend a peptide, design a regimen, or translate a study protocol into personal dosing. It does not identify prescribers, compounding pharmacies, research suppliers, or purchasing routes. It cannot verify the contents of a commercial vial from a label or certificate supplied by its seller.

Questions about individual treatment, contraindications, interactions, or access belong with a licensed clinician and pharmacist in the relevant jurisdiction. Questions about competitive-sport status belong with the governing antidoping authority. This boundary is the distinction between an editorial digest and a clinical or commercial service.